Application 018858

Type
NDA
Sponsor
MYLAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001INDOMETHACININDOMETHACINCAPSULE;ORAL25MGNoNo
002INDOMETHACININDOMETHACINCAPSULE;ORAL50MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-0143IndomethacinindomethacinMylan Pharmaceuticals Inc.NDACurrent
0440-1652IndomethacinindomethacinLiberty Pharmaceuticals, Inc.NDACurrent
10544-234IndomethacinindomethacinBlenheim Pharmacal, Inc.NDACurrent
33261-133IndomethacinindomethacinAidarex Pharmaceuticals LLCNDACurrent
51079-190IndomethacinindomethacinMylan Institutional Inc.NDACurrent
55289-147IndomethacinindomethacinPD-Rx Pharmaceuticals, Inc.NDACurrent
67046-330IndomethacinIndomethacinContract Pharmacy Services-PANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
80343SUPPL 2024-11-25
80301SUPPL 2024-11-22
80300SUPPL 2024-11-22
67337SUPPL2021-05-03
67336SUPPL2021-05-03
67245SUPPL2021-04-29
16073SUPPL2016-05-12
16072SUPPL2016-05-12
33626SUPPL2016-05-11
11353SUPPL2016-05-11